Monitoring adverse reactions to drugs: toward a therapeutic audit.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000553:Ambulatory Care; D000700:Analgesics / Q000009:adverse effects; D000741:Anemia, Aplastic / Q000139:chemically induced; D001315:Australia; D001634:Bibliographies as Topic; D002701:Chloramphenicol / Q000008:administration & dosage / Q000009:adverse effects; D011307:Drug Prescriptions; D004363:Drug Utilization; D064420:Drug-Related Side Effects and Adverse Reactions; D004812:Epidemiologic Methods; D005060:Europe; D006761:Hospitals; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007231:Infant, Newborn; D007256:Information Systems; D008499:Medical Records; D012042:Registries; D013792:Thalidomide / Q000009:adverse effects; D014481:United States; D014944:World Health Organization
D000700:Analgesics; D007004:Hypoglycemic Agents; D013792:Thalidomide; D002701:Chloramphenicol